Literature DB >> 6879116

Infective endocarditis caused by uncommon bacteria.

E Ben-Chetrit, M Nashif, Y Levo.   

Abstract

The present study is an attempt to define the uncommon bacteria (UB) causing endocarditis and to evaluate their prevalence and clinical significance. Review of 13 series (including ours) revealed that UB were the infecting organisms in 105/1989 patients (5.3%). The leading bacteria were: Pneumococcus, Haemophilus sp., Corynebacterium sp., Neisseria sp., Streptobacillus moniliformis, Cardiobacterium hominis and Erysipelothrix sp. These data are similar to those obtained from 111 sporadic case reports published in English during the last 6 yr and cited in the Index Medicus. Infection by UB usually resembles that by the common bacteria. However, Haemophilus sp. seems to affect mainly the young and is associated with major arterial occlusions, and Brucella is claimed to have a greater affinity to the aortic valve. UB are more frequent in patients with polymicrobial infections and their diagnosis is often delayed. Greater awareness to the possibility of infections with UB is needed for early diagnosis and improved prognosis.

Entities:  

Mesh:

Year:  1983        PMID: 6879116     DOI: 10.3109/inf.1983.15.issue-2.09

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Invasive infections caused by Haemophilus species other than Haemophilus influenzae.

Authors:  B Trollfors; J E Brorson; B Claesson; T Sandberg
Journal:  Infection       Date:  1985 Jan-Feb       Impact factor: 3.553

2.  Cardiobacterium hominis and Cardiobacterium valvarum: Two Case Stories with Infective Episodes in Pacemaker Treated Patients.

Authors:  Tina Bennett Bonavent; Xiaohui Chen Nielsen; Kjeld Skødebjerg Kristensen; Nikolaj Ihlemann; Claus Moser; Jens Jørgen Christensen
Journal:  Open Microbiol J       Date:  2016-11-30

3.  Corynebacterium endocarditis species-specific risk factors and outcomes.

Authors:  Jaime Belmares; Stephanie Detterline; Janet B Pak; Jorge P Parada
Journal:  BMC Infect Dis       Date:  2007-02-06       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.